Paying users zone. Data is covered by hidden.

  • Get to AbbVie Inc. for $19.99, or

  • get to entire website for at least 3 months from $49.99.


Visa Mastercard Maestro American Express Discover JCB    PayPal

Microsoft Excel LibreOffice Calc


Statement of Cash Flows

Difficulty: Beginner

The cash flow statement provides information about a company’s cash receipts and cash payments during an accounting period, showing how these cash flaws link the ending cash balance to the beginning balance shown on the company’s statement of financial position.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

AbbVie Inc., Consolidated Statement of Cash Flows

USD $ in millions

Microsoft Excel LibreOffice Calc
12 months ended Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Net earnings hidden hidden hidden hidden hidden
Depreciation hidden hidden hidden hidden hidden
Amortization of intangible assets hidden hidden hidden hidden hidden
Change in fair value of contingent consideration liabilities hidden hidden hidden hidden hidden
Stock-based compensation hidden hidden hidden hidden hidden
Upfront costs and milestones related to collaborations hidden hidden hidden hidden hidden
Devaluation loss related to Venezuela hidden hidden hidden hidden hidden
Intangible asset impairment hidden hidden hidden hidden hidden
Impacts related to U.S. tax reform hidden hidden hidden hidden hidden
Other, net hidden hidden hidden hidden hidden
Accounts receivable hidden hidden hidden hidden hidden
Inventories hidden hidden hidden hidden hidden
Prepaid expenses and other assets hidden hidden hidden hidden hidden
Accounts payable and other liabilities hidden hidden hidden hidden hidden
Changes in operating assets and liabilities, net of acquisitions hidden hidden hidden hidden hidden
Adjustments to reconcile net earnings to net cash from operating activities hidden hidden hidden hidden hidden
Cash flows from operating activities hidden hidden hidden hidden hidden
Acquisition of businesses, net of cash acquired hidden hidden hidden hidden hidden
Other acquisitions and investments hidden hidden hidden hidden hidden
Acquisitions of property and equipment hidden hidden hidden hidden hidden
Purchases of investment securities hidden hidden hidden hidden hidden
Sales and maturities of investment securities hidden hidden hidden hidden hidden
Other hidden hidden hidden hidden hidden
Cash flows from investing activities hidden hidden hidden hidden hidden
Net change in short-term borrowings hidden hidden hidden hidden hidden
Proceeds from issuance of long-term debt hidden hidden hidden hidden hidden
Repayments of long-term debt and lease obligations hidden hidden hidden hidden hidden
Debt issuance cost hidden hidden hidden hidden hidden
Dividends paid hidden hidden hidden hidden hidden
Purchases of treasury stock hidden hidden hidden hidden hidden
Proceeds from the exercise of stock options hidden hidden hidden hidden hidden
Payments of contingent consideration liabilities hidden hidden hidden hidden hidden
Net transactions with Abbott Laboratories, excluding non-cash items hidden hidden hidden hidden hidden
Other, net hidden hidden hidden hidden hidden
Cash flows from financing activities hidden hidden hidden hidden hidden
Effect of exchange rate changes on cash and equivalents hidden hidden hidden hidden hidden
Net change in cash and equivalents hidden hidden hidden hidden hidden
Cash and equivalents, beginning of year hidden hidden hidden hidden hidden
Cash and equivalents, end of year hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-20), 10-K (filing date: 2014-02-21).

Item Description The company
Cash flows from operating activities Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. AbbVie Inc.’s cash flows from operating activities declined from 2015 to 2016 but then increased from 2016 to 2017 exceeding 2015 level.
Cash flows from investing activities Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. AbbVie Inc.’s cash flows from investing activities increased from 2015 to 2016 and from 2016 to 2017.
Cash flows from financing activities Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. AbbVie Inc.’s cash flows from financing activities declined from 2015 to 2016 and from 2016 to 2017.